- $5.01bn
- $5.48bn
- $1.78bn
- 50
- 66
- 79
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,053 | 1,427 | 1,232 | 1,603 | 1,784 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,721 | 5,750 | 2,134 | 1,568 | 1,760 |
Operating Profit | -668 | -4,323 | -902 | 34.8 | 24.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -63.8 | -5,117 | -4,439 | 225 | 84.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -192 | -4,858 | -4,493 | 182 | 867 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -198 | -4,856 | -4,500 | 177 | 865 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -198 | -4,856 | -4,500 | 177 | 865 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.74 | -33.1 | -53.4 | 2.73 | 11.5 |
Dividends per Share |